← Back to Search

Type 2 diabetes for Diabetes

N/A
Waitlist Available
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up subjects will complete both glycogen loading and no glycogen loading visits within approximately 6 weeks
Awards & highlights

Study Summary

This trial is testing whether having more or less glycogen in your liver affects how your body regulates blood sugar levels overnight. both people with and without diabetes will be studied.

Eligible Conditions
  • Diabetes
  • Type 2 Diabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~subjects will complete both glycogen loading and no glycogen loading visits within approximately 6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and subjects will complete both glycogen loading and no glycogen loading visits within approximately 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Hepatic Glycogen Content and Rates of Gluconeogenesis in Subjects With Type 2 Diabetes
Secondary outcome measures
Rates of Gluconeogenesis in Healthy Subjects
Rates of Glycogenolysis in Subjects With Type 2 Diabetes

Trial Design

2Treatment groups
Experimental Treatment
Group I: Type 2 diabetesExperimental Treatment2 Interventions
Participants with Type 2 Diabetes received Glycogen loading (GL) and Non-Glycogen loading (NGL) meal in a randomized manner.
Group II: Participants without diabetesExperimental Treatment2 Interventions
Participants with no Diabetes received Glycogen loading (GL) and Non-Glycogen loading (NGL) meal in a randomized manner.

Find a Location

Who is running the clinical trial?

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,359 Previous Clinical Trials
4,314,557 Total Patients Enrolled
107 Trials studying Diabetes
138,663 Patients Enrolled for Diabetes
University of Alabama at BirminghamLead Sponsor
1,590 Previous Clinical Trials
2,281,448 Total Patients Enrolled
15 Trials studying Diabetes
41,298 Patients Enrolled for Diabetes
Mayo ClinicOTHER
3,212 Previous Clinical Trials
3,767,004 Total Patients Enrolled
22 Trials studying Diabetes
6,803 Patients Enrolled for Diabetes

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~7 spots leftby Apr 2025